IMPACT OF A COST SHARING DRUG INSURANCE PLAN ON DRUG UTILIZATION AMONG INDIVIDUALS RECEIVING SOCIAL ASSISTANCE
Author(s)
LeLorier J, Blais L, Couture J, Rahme E, Centre de recherche, Centre hospitalier de l’Université de Montréal, Campus Hôtel-Dieu, Quebec, Canada
OBJECTIVE: In August 1996, the Régie de l’assurance-maladie du Québec (RAMQ) introduced a new drug insurance plan for all residents of Quebec, a Canadian province. Before this insurance plan, individuals receiving social assistance had all their medications paid by the RAMQ. Now, they have to pay up to 50 $ per quarter for their medications in terms of deductible and co-insurance. Concerned that this financial constraint could have an impact on the use of medications, we investigated whether the consumption of three classes of medications (neuroleptics, anti-convulsivants and inhaled corticosteroids) had been modified after the drug plan was introduced. METHODS: Using the computerized databases of the RAMQ and time series analysis, we analyzed the variation in the number of prescriptions dispensed per month in Quebec from August 1992 to July 1997, for each drug class. RESULTS: Users of inhaled corticosteroids were the most affected with a statistically significant decrease of 28 % in the number of dispensed prescriptions for the 11 months following the drug plan (August 1996 to June 1997) as compared with the same period one year before. For the same period, we were expecting an increase of 9 % according to the trend seen from August 1992 to July 1996. For users of neuroleptics and anti-convulsivants we found a 1 % decrease while we were expecting an increase of 7 and 8 %, respectively. CONCLUSIONS: Following the introduction of the Quebec drug plan, individuals receiving social assistance decreased significantly their consumption of inhaled corticosteroids, medications that are considered to be effective and essential.
Conference/Value in Health Info
1998-12, ISPOR Europe 1998, Cologne, Germany
Value in Health, Vol. 2, No. 1 (January/February 1999)
Code
PN6
Topic
Health Policy & Regulatory
Topic Subcategory
Pricing Policy & Schemes
Disease
Multiple Diseases